[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Pharmaceutical Asset Management Market Size, Status and Forecast 2020-2026

September 2020 | 96 pages | ID: CFF5DEB3D616EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Pharmaceutical Asset Management status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutical Asset Management development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
  • McKesson Corporation
  • Cerner Corporation
  • Siemens Healthcare
  • GE Healthcare
  • Allscripts
  • Epic System
  • IBM Corporation
Market segment by Type, the product can be split into
  • Hardware (Pharma Asset)
  • Software (Pharma Asset)
Market segment by Application, split into
  • Anti-drug Counterfeiting
  • Supply Chain Management
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Pharmaceutical Asset Management status, future forecast, growth opportunity, key market and key players.
  • To present the Pharmaceutical Asset Management development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Pharmaceutical Asset Management are as follows:
  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmaceutical Asset Management Revenue
1.4 Market Analysis by Type
  1.4.1 Global Pharmaceutical Asset Management Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Hardware (Pharma Asset)
  1.4.3 Software (Pharma Asset)
1.5 Market by Application
  1.5.1 Global Pharmaceutical Asset Management Market Share by Application: 2020 VS 2026
  1.5.2 Anti-drug Counterfeiting
  1.5.3 Supply Chain Management
1.6 Coronavirus Disease 2019 (Covid-19): Pharmaceutical Asset Management Industry Impact
  1.6.1 How the Covid-19 is Affecting the Pharmaceutical Asset Management Industry
    1.6.1.1 Pharmaceutical Asset Management Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Pharmaceutical Asset Management Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Pharmaceutical Asset Management Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Pharmaceutical Asset Management Market Perspective (2015-2026)
2.2 Pharmaceutical Asset Management Growth Trends by Regions
  2.2.1 Pharmaceutical Asset Management Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Pharmaceutical Asset Management Historic Market Share by Regions (2015-2020)
  2.2.3 Pharmaceutical Asset Management Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Pharmaceutical Asset Management Market Growth Strategy
  2.3.6 Primary Interviews with Key Pharmaceutical Asset Management Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Pharmaceutical Asset Management Players by Market Size
  3.1.1 Global Top Pharmaceutical Asset Management Players by Revenue (2015-2020)
  3.1.2 Global Pharmaceutical Asset Management Revenue Market Share by Players (2015-2020)
  3.1.3 Global Pharmaceutical Asset Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmaceutical Asset Management Market Concentration Ratio
  3.2.1 Global Pharmaceutical Asset Management Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutical Asset Management Revenue in 2019
3.3 Pharmaceutical Asset Management Key Players Head office and Area Served
3.4 Key Players Pharmaceutical Asset Management Product Solution and Service
3.5 Date of Enter into Pharmaceutical Asset Management Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Pharmaceutical Asset Management Historic Market Size by Type (2015-2020)
4.2 Global Pharmaceutical Asset Management Forecasted Market Size by Type (2021-2026)

5 PHARMACEUTICAL ASSET MANAGEMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Pharmaceutical Asset Management Market Size by Application (2015-2020)
5.2 Global Pharmaceutical Asset Management Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Pharmaceutical Asset Management Market Size (2015-2020)
6.2 Pharmaceutical Asset Management Key Players in North America (2019-2020)
6.3 North America Pharmaceutical Asset Management Market Size by Type (2015-2020)
6.4 North America Pharmaceutical Asset Management Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Pharmaceutical Asset Management Market Size (2015-2020)
7.2 Pharmaceutical Asset Management Key Players in Europe (2019-2020)
7.3 Europe Pharmaceutical Asset Management Market Size by Type (2015-2020)
7.4 Europe Pharmaceutical Asset Management Market Size by Application (2015-2020)

8 CHINA

8.1 China Pharmaceutical Asset Management Market Size (2015-2020)
8.2 Pharmaceutical Asset Management Key Players in China (2019-2020)
8.3 China Pharmaceutical Asset Management Market Size by Type (2015-2020)
8.4 China Pharmaceutical Asset Management Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Pharmaceutical Asset Management Market Size (2015-2020)
9.2 Pharmaceutical Asset Management Key Players in Japan (2019-2020)
9.3 Japan Pharmaceutical Asset Management Market Size by Type (2015-2020)
9.4 Japan Pharmaceutical Asset Management Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Pharmaceutical Asset Management Market Size (2015-2020)
10.2 Pharmaceutical Asset Management Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmaceutical Asset Management Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmaceutical Asset Management Market Size by Application (2015-2020)

11 INDIA

11.1 India Pharmaceutical Asset Management Market Size (2015-2020)
11.2 Pharmaceutical Asset Management Key Players in India (2019-2020)
11.3 India Pharmaceutical Asset Management Market Size by Type (2015-2020)
11.4 India Pharmaceutical Asset Management Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Pharmaceutical Asset Management Market Size (2015-2020)
12.2 Pharmaceutical Asset Management Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmaceutical Asset Management Market Size by Type (2015-2020)
12.4 Central & South America Pharmaceutical Asset Management Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 McKesson Corporation
  13.1.1 McKesson Corporation Company Details
  13.1.2 McKesson Corporation Business Overview and Its Total Revenue
  13.1.3 McKesson Corporation Pharmaceutical Asset Management Introduction
  13.1.4 McKesson Corporation Revenue in Pharmaceutical Asset Management Business (2015-2020))
  13.1.5 McKesson Corporation Recent Development
13.2 Cerner Corporation
  13.2.1 Cerner Corporation Company Details
  13.2.2 Cerner Corporation Business Overview and Its Total Revenue
  13.2.3 Cerner Corporation Pharmaceutical Asset Management Introduction
  13.2.4 Cerner Corporation Revenue in Pharmaceutical Asset Management Business (2015-2020)
  13.2.5 Cerner Corporation Recent Development
13.3 Siemens Healthcare
  13.3.1 Siemens Healthcare Company Details
  13.3.2 Siemens Healthcare Business Overview and Its Total Revenue
  13.3.3 Siemens Healthcare Pharmaceutical Asset Management Introduction
  13.3.4 Siemens Healthcare Revenue in Pharmaceutical Asset Management Business (2015-2020)
  13.3.5 Siemens Healthcare Recent Development
13.4 GE Healthcare
  13.4.1 GE Healthcare Company Details
  13.4.2 GE Healthcare Business Overview and Its Total Revenue
  13.4.3 GE Healthcare Pharmaceutical Asset Management Introduction
  13.4.4 GE Healthcare Revenue in Pharmaceutical Asset Management Business (2015-2020)
  13.4.5 GE Healthcare Recent Development
13.5 Allscripts
  13.5.1 Allscripts Company Details
  13.5.2 Allscripts Business Overview and Its Total Revenue
  13.5.3 Allscripts Pharmaceutical Asset Management Introduction
  13.5.4 Allscripts Revenue in Pharmaceutical Asset Management Business (2015-2020)
  13.5.5 Allscripts Recent Development
13.6 Epic System
  13.6.1 Epic System Company Details
  13.6.2 Epic System Business Overview and Its Total Revenue
  13.6.3 Epic System Pharmaceutical Asset Management Introduction
  13.6.4 Epic System Revenue in Pharmaceutical Asset Management Business (2015-2020)
  13.6.5 Epic System Recent Development
13.7 IBM Corporation
  13.7.1 IBM Corporation Company Details
  13.7.2 IBM Corporation Business Overview and Its Total Revenue
  13.7.3 IBM Corporation Pharmaceutical Asset Management Introduction
  13.7.4 IBM Corporation Revenue in Pharmaceutical Asset Management Business (2015-2020)
  13.7.5 IBM Corporation Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Pharmaceutical Asset Management Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmaceutical Asset Management Revenue
Table 3. Ranking of Global Top Pharmaceutical Asset Management Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pharmaceutical Asset Management Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hardware (Pharma Asset)
Table 6. Key Players of Software (Pharma Asset)
Table 7. COVID-19 Impact Global Market: (Four Pharmaceutical Asset Management Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Pharmaceutical Asset Management Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Pharmaceutical Asset Management Players to Combat Covid-19 Impact
Table 12. Global Pharmaceutical Asset Management Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Pharmaceutical Asset Management Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Pharmaceutical Asset Management Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Pharmaceutical Asset Management Market Share by Regions (2015-2020)
Table 16. Global Pharmaceutical Asset Management Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Pharmaceutical Asset Management Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Pharmaceutical Asset Management Market Growth Strategy
Table 22. Main Points Interviewed from Key Pharmaceutical Asset Management Players
Table 23. Global Pharmaceutical Asset Management Revenue by Players (2015-2020) (Million US$)
Table 24. Global Pharmaceutical Asset Management Market Share by Players (2015-2020)
Table 25. Global Top Pharmaceutical Asset Management Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Asset Management as of 2019)
Table 26. Global Pharmaceutical Asset Management by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Pharmaceutical Asset Management Product Solution and Service
Table 29. Date of Enter into Pharmaceutical Asset Management Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Pharmaceutical Asset Management Market Size by Type (2015-2020) (Million US$)
Table 32. Global Pharmaceutical Asset Management Market Size Share by Type (2015-2020)
Table 33. Global Pharmaceutical Asset Management Revenue Market Share by Type (2021-2026)
Table 34. Global Pharmaceutical Asset Management Market Size Share by Application (2015-2020)
Table 35. Global Pharmaceutical Asset Management Market Size by Application (2015-2020) (Million US$)
Table 36. Global Pharmaceutical Asset Management Market Size Share by Application (2021-2026)
Table 37. North America Key Players Pharmaceutical Asset Management Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Pharmaceutical Asset Management Market Share (2019-2020)
Table 39. North America Pharmaceutical Asset Management Market Size by Type (2015-2020) (Million US$)
Table 40. North America Pharmaceutical Asset Management Market Share by Type (2015-2020)
Table 41. North America Pharmaceutical Asset Management Market Size by Application (2015-2020) (Million US$)
Table 42. North America Pharmaceutical Asset Management Market Share by Application (2015-2020)
Table 43. Europe Key Players Pharmaceutical Asset Management Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Pharmaceutical Asset Management Market Share (2019-2020)
Table 45. Europe Pharmaceutical Asset Management Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Pharmaceutical Asset Management Market Share by Type (2015-2020)
Table 47. Europe Pharmaceutical Asset Management Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Pharmaceutical Asset Management Market Share by Application (2015-2020)
Table 49. China Key Players Pharmaceutical Asset Management Revenue (2019-2020) (Million US$)
Table 50. China Key Players Pharmaceutical Asset Management Market Share (2019-2020)
Table 51. China Pharmaceutical Asset Management Market Size by Type (2015-2020) (Million US$)
Table 52. China Pharmaceutical Asset Management Market Share by Type (2015-2020)
Table 53. China Pharmaceutical Asset Management Market Size by Application (2015-2020) (Million US$)
Table 54. China Pharmaceutical Asset Management Market Share by Application (2015-2020)
Table 55. Japan Key Players Pharmaceutical Asset Management Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Pharmaceutical Asset Management Market Share (2019-2020)
Table 57. Japan Pharmaceutical Asset Management Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Pharmaceutical Asset Management Market Share by Type (2015-2020)
Table 59. Japan Pharmaceutical Asset Management Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Pharmaceutical Asset Management Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Pharmaceutical Asset Management Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Pharmaceutical Asset Management Market Share (2019-2020)
Table 63. Southeast Asia Pharmaceutical Asset Management Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Pharmaceutical Asset Management Market Share by Type (2015-2020)
Table 65. Southeast Asia Pharmaceutical Asset Management Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Pharmaceutical Asset Management Market Share by Application (2015-2020)
Table 67. India Key Players Pharmaceutical Asset Management Revenue (2019-2020) (Million US$)
Table 68. India Key Players Pharmaceutical Asset Management Market Share (2019-2020)
Table 69. India Pharmaceutical Asset Management Market Size by Type (2015-2020) (Million US$)
Table 70. India Pharmaceutical Asset Management Market Share by Type (2015-2020)
Table 71. India Pharmaceutical Asset Management Market Size by Application (2015-2020) (Million US$)
Table 72. India Pharmaceutical Asset Management Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Pharmaceutical Asset Management Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Pharmaceutical Asset Management Market Share (2019-2020)
Table 75. Central & South America Pharmaceutical Asset Management Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Pharmaceutical Asset Management Market Share by Type (2015-2020)
Table 77. Central & South America Pharmaceutical Asset Management Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Pharmaceutical Asset Management Market Share by Application (2015-2020)
Table 79. McKesson Corporation Company Details
Table 80. McKesson Corporation Business Overview
Table 81. McKesson Corporation Product
Table 82. McKesson Corporation Revenue in Pharmaceutical Asset Management Business (2015-2020) (Million US$)
Table 83. McKesson Corporation Recent Development
Table 84. Cerner Corporation Company Details
Table 85. Cerner Corporation Business Overview
Table 86. Cerner Corporation Product
Table 87. Cerner Corporation Revenue in Pharmaceutical Asset Management Business (2015-2020) (Million US$)
Table 88. Cerner Corporation Recent Development
Table 89. Siemens Healthcare Company Details
Table 90. Siemens Healthcare Business Overview
Table 91. Siemens Healthcare Product
Table 92. Siemens Healthcare Revenue in Pharmaceutical Asset Management Business (2015-2020) (Million US$)
Table 93. Siemens Healthcare Recent Development
Table 94. GE Healthcare Company Details
Table 95. GE Healthcare Business Overview
Table 96. GE Healthcare Product
Table 97. GE Healthcare Revenue in Pharmaceutical Asset Management Business (2015-2020) (Million US$)
Table 98. GE Healthcare Recent Development
Table 99. Allscripts Company Details
Table 100. Allscripts Business Overview
Table 101. Allscripts Product
Table 102. Allscripts Revenue in Pharmaceutical Asset Management Business (2015-2020) (Million US$)
Table 103. Allscripts Recent Development
Table 104. Epic System Company Details
Table 105. Epic System Business Overview
Table 106. Epic System Product
Table 107. Epic System Revenue in Pharmaceutical Asset Management Business (2015-2020) (Million US$)
Table 108. Epic System Recent Development
Table 109. IBM Corporation Company Details
Table 110. IBM Corporation Business Overview
Table 111. IBM Corporation Product
Table 112. IBM Corporation Revenue in Pharmaceutical Asset Management Business (2015-2020) (Million US$)
Table 113. IBM Corporation Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Pharmaceutical Asset Management Market Share by Type: 2020 VS 2026
Figure 2. Hardware (Pharma Asset) Features
Figure 3. Software (Pharma Asset) Features
Figure 4. Global Pharmaceutical Asset Management Market Share by Application: 2020 VS 2026
Figure 5. Anti-drug Counterfeiting Case Studies
Figure 6. Supply Chain Management Case Studies
Figure 7. Pharmaceutical Asset Management Report Years Considered
Figure 8. Global Pharmaceutical Asset Management Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Pharmaceutical Asset Management Market Share by Regions: 2020 VS 2026
Figure 10. Global Pharmaceutical Asset Management Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Pharmaceutical Asset Management Market Share by Players in 2019
Figure 13. Global Top Pharmaceutical Asset Management Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Asset Management as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Pharmaceutical Asset Management Revenue in 2019
Figure 15. North America Pharmaceutical Asset Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Pharmaceutical Asset Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Pharmaceutical Asset Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Pharmaceutical Asset Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Pharmaceutical Asset Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Pharmaceutical Asset Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Pharmaceutical Asset Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. McKesson Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. McKesson Corporation Revenue Growth Rate in Pharmaceutical Asset Management Business (2015-2020)
Figure 24. Cerner Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Cerner Corporation Revenue Growth Rate in Pharmaceutical Asset Management Business (2015-2020)
Figure 26. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Siemens Healthcare Revenue Growth Rate in Pharmaceutical Asset Management Business (2015-2020)
Figure 28. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. GE Healthcare Revenue Growth Rate in Pharmaceutical Asset Management Business (2015-2020)
Figure 30. Allscripts Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Allscripts Revenue Growth Rate in Pharmaceutical Asset Management Business (2015-2020)
Figure 32. Epic System Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Epic System Revenue Growth Rate in Pharmaceutical Asset Management Business (2015-2020)
Figure 34. IBM Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. IBM Corporation Revenue Growth Rate in Pharmaceutical Asset Management Business (2015-2020)
Figure 36. Bottom-up and Top-down Approaches for This Report
Figure 37. Data Triangulation
Figure 38. Key Executives Interviewed


More Publications